Proteolytic Enzymes in Inflammation: Rationale for Use

REFERENCES

• Erbecke, U.: Uber Gewebsreizung und Gefässreaktion. Arch. f. d. ges. Physiol. 199:198–216, 1923.
   Google Scholar
• Lewis, T.: The Blood Vessels of the Human Skin and Their Responses. London, Shaw and Sons, 1927, p. 322.
   Google Scholar
• Krogh, A.: The Anatomy and Physiology of Capillaries. New Haven, Connecticut, Yale University Press, 1922, p. 276.
   Google Scholar
• Cited by UNGAR, G.: Inflammation and its control; a biochemical approach. Lancet 2:742–746 (October 18) 1952.
   PubMedGoogle Scholar
• Dragstedt, C. A.: Anaphylaxis. Physiol. Rev. 21:563–587 (October) 1941.
   Google Scholar
• Feldberg, W.: Histamine and anaphylaxis. Ann. Rev. Physiol. 3:671–694, 1941.
   Google Scholar
• Duthrie. E. S. and Chain, E.: A polypeptide responsible for some of the phenomena of acute inflammation. Brit. J. Exper. Path. 20:417–429 (October) 1939.
   Google Scholar
• Menkin, V.: Dynamics of Inflammation. An Inquiry Into the Mechanism of Infectious Processes. New York, The Macmillan Company, 1940, p. 244.
   Google Scholar
• Rocha E Silva, M., Beraldo, W. T. and Rosenfeld, G.: Brady, kinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and trypsin. Am. J. Physiol. 156:261–273 (February) 1949.
   PubMed Web of Science ®Google Scholar
• Spector, W. G.: The role of some higher peptides in inflammation. J. Path. & Bact. 63:93–110 (January) 1951.
   PubMedGoogle Scholar
• Hughes, W. H.: Failure of immunity responses in local disease. Brit. M. J. 1:366–368 (March 17) 1945.
   PubMedGoogle Scholar
• Hughes, W. H.: The fibrin barrier regarded as a filter in inflammation. Brit. J. Exper. Path. 29:173–180 (April) 1948.
   PubMedGoogle Scholar
• Dubos, R. J.: Biochemical determinants of infection. Bull. New York Acad. Med. 31:5–19 (January) 1955.
   PubMedGoogle Scholar
• Tompkins, E. H.: Resting reticuloendothelial cells and their “fluid vacuoles”: Reactions to potassium, tonicity and albumin. Bull. Johns Hopkins Hosp. 92:79–98 (February) 1953.
   PubMedGoogle Scholar
• Tompkins, E. H. and Grillo, M. A.: Factors favoring phagocytosis by reticuloendothelial cells early in inflammation. Am. J. Path. 29:217–226 (March-April) 1953.
   PubMed Web of Science ®Google Scholar
• Wood, W. B., Jr., Smith, M. R. and Watson, B.: Studies on the mechanism of recovery in pneumococcal pneumonia. IV. The mechanism of phagocytosis in the absence of antibody. J. Exper. Med. 84:387–402 (October) 1946.
   Google Scholar
• Smith, M. R. and Wood, W. B., Jr.: Studies on the mechanism of recovery in pneumonia due to Friedländer's bacillus. III. The role of “surface phagocytosis” in the destruction of microorganisms in the lung. J. Exper. Med. 86:257–266 (September) 1947.
   Google Scholar
• Wood, W. B., Jr.: Studies on the cellular immunity of acute bacterial infections. Harvey Lect., series 47, 1951–1952. New York, Academic Press, Inc., 1953, pp. 72–98.
   Google Scholar
• Smith, M. R. and Wood, W. B., Jr.: Cited by Smith, M. R. and Wood, W. B., Jr.17
   Google Scholar
• Metschnikoff, E.: Die Lehre von den Phagocyten und deren experimentelle Grundlagen. In Kolle, W. and von Wasserman, A.: Handbrick der Pathogenen Mikroorganismen. Jena, Gustav Fischer, 1913, pp. 655–731.
   Google Scholar
• Roux, P. and Jones, F. S.: The protection of pathogenic microorganisms by living tissue cells. J. Exper. Med. 23:601–612 (May) 1916.
   PubMedGoogle Scholar
• Magoffin, R. L. and Spink, W. W.: The protection of intracellular Brucella against streptomycin alone and in combination with other drugs. J. Lab. & Clin. Med. 37:924–930 (June) 1951.
   PubMed Web of Science ®Google Scholar
• Suter, E.: Multiplication of tubercle bacilli within phagocytes cultivated in vivo and effect of streptomycin and isonicotinic acid hydrazide. Am. Rev. Tuberc. 65:775–776 (June) 1952.
   PubMedGoogle Scholar
• Mackaness, G. B.: The action of drugs on intracellular tubercle bacilli. J. Path. & Bact. 64:429–446 (July) 1952.
   PubMedGoogle Scholar
• Mackaness, G. B. and Smith, N.: The bactericidal action of isoniazid, streptomycin and Terramycin on extracellular and intracellular tubercle bacilli. Am. Rev. Tuberc. 67:322–340 (March) 1953.
   PubMedGoogle Scholar
• Dubos, R. J.: The effect of organic acids on mammalian bacilli. J. Exper. Med. 92:319–332 (October) 1950.
   PubMed Web of Science ®Google Scholar
• Dubos, R. J.: Effect of ketone bodies and other metabolites on the survival and multiplication of staphylococci and tubercle bacilli. J. Exper. Med. 98:145–155 (August) 1953.
   PubMed Web of Science ®Google Scholar
• Dubos, R. J.: The effect of lipids and serum albumin on bacterial growth. J. Exper. Med. 85:9–22 (January) 1947.
   PubMed Web of Science ®Google Scholar
• Nieman, C.: Influence of trace amounts of fatty acids on the growth of microorganisms. Bact. Rev. 18:147–163 (June) 1954.
   PubMedGoogle Scholar
• Tillett, W. S. and Garner, R. L.: The fibrinolytic activity of hemolytic streptococci. J. Exper. Med. 58:485–502 (October) 1933.
   PubMedGoogle Scholar
• Tillett, W. S., Sherry, S. and Christensen, L. R.: Streptococcal desoxyribonuclease: Significance in lysis of purulent exudates and production by strains of hemolytic streptococci. Proc. Soc. Exper. Biol. & Med. 68:184–188 (May) 1949.
   Web of Science ®Google Scholar
• McCarty, M.: Occurrence of nucleases in culture filtrates of group A hemolytic streptococci. J. Exper. Med. 88:181–188 (August) 1948.
   PubMed Web of Science ®Google Scholar
• Elliott, S. D.: Proteolytic enzyme produced by group 14 streptococci with type-specific M antigen. J. Exper. Med. 81:573–592 (June) 1945.
   PubMed Web of Science ®Google Scholar
• Meyer, K., Chaffee, E., Hobby, C. L. and Dawson, M. H.: Hydrolysis of hyaluronic acid by bacterial enzymes. J. Exper. Med. 71:137–146 (February) 1940.
   PubMedGoogle Scholar
• Meyer, K., Chaffee, E., Hobby, C. L. and Dawson, M. H.: Hyaluronidases of bacterial and animal origin. J. Exper. Med. 73:309–326 (March) 1941.
   PubMedGoogle Scholar
• MacLeod, C. M. and Pappenheimer, A. M., Jr.: Properties of bacteria which enable them to cause disease. In Dubos, R. J.: Bacterial and Mycotic Infections of Man. Philadelphia, J. B. Lippincott Company, 1948, pp. 69–89.
   Google Scholar
• Smith, W. and Hale, J. H.: The nature and mode of action of Staphylococcus coagulase. Brit. J. Exper. Path. 25:101–110 (June) 1944.
   Google Scholar
• Crowley, N.: Hyaluronidase production by hemolytic streptococci of human origin. J. Path. & Bact. 56:27–35 (January) 1944.
   Google Scholar
• Dubos, R. J.: Biological Determinants of Microbial Diseases. Cambridge, Massachusetts, Harvard University Press, 1954, p. 152.
   Google Scholar
• Johnson, A. J.: Cytological studies in association with local injections of streptokinase-streptodornase in patients. J. Clin. Investigation 29:1376–1386 (October) 1950.
   PubMed Web of Science ®Google Scholar
• Folkow, B., Haeger, K. and Kahlson, G.: Observations on reactive hyperemia as related to histamine, on drugs antagonizing vasodilatation induced by histamine and on vasodilator properties of adenosine triphosphate. Acta physiol. Scandinav. 15:264–278, 1948.
   Google Scholar
• Green, H. N. and Stoner, H. B.: The present status of the adenine nucleotides in the bodily response to injury. Brit. M. J. 1:805–809 (April 8) 1950.
   PubMedGoogle Scholar
• Barnard, R. D.: Elucidation of chemically defined haptenes for competitive inhibition of aggressin activity. Quart. Rev. Allergy and Applied Immunol. 8:78–93 (March) 1954.
   PubMedGoogle Scholar
• Miller, J. M., Surmonte, J. A., Ginsberg, M. and Ablondi, F. B.: Clinical experience with the injection of streptokinase intramuscularly in the treatment of infection and edema. Maryland State J. Med. 4:188–193 (April) 1955.
   PubMedGoogle Scholar
• Sherry, S. and Goeller, J.: Extent of the enzymatic degradation of desoxyribonucleic acid (DNA) in purulent exudates by streptodornase. J. Clin. Investigation 29:1588–1594 (December) 1950.
   PubMed Web of Science ®Google Scholar